BCL6B Contributes to Ocular Vascular Diseases via Notch Signal Silencing

202312 citationsJournal Articlehybrid Open Access

Authors

These data indicate that BCL6B may be a novel therapeutic target for ocular vascular diseases characterized by ocular neovascularization and edema.

Good health and well-being

Published in: Arteriosclerosis Thrombosis and Vascular Biology

Volume 43, Issue 6, pp. 927-942

Field-Weighted Citation Impact: 4.02